We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Systems Offer Cost-Effective Urinalysis at Any Lab Scale

By LabMedica International staff writers
Posted on 22 Jul 2019
Print article
Image: The LAURA automated urine analyzer (Photo courtesy of Erba Mannheim).
Image: The LAURA automated urine analyzer (Photo courtesy of Erba Mannheim).
Image: The LAURA XL automated urine analyzer (Photo courtesy of Erba Mannheim).
Image: The LAURA XL automated urine analyzer (Photo courtesy of Erba Mannheim).
With the growing prevalence of kidney-related diseases, proper screening and detection have become an increasing priority for clinicians. Two newly introduced systems, LAURA and LAURA XL, now aim to fill the need for such reliable, automated, and affordable urinalysis.

LAURA is a semi-automated strip reader using reflectance photometry for objective evaluation of color reactions on diagnostic pads. It offers evaluation of 12 clinically significant parameters: specific gravity, leukocytes, nitrites, pH, protein, glucose, ketones, urobilinogen, bilirubin, blood, microalbumin, and creatinine, as well as calculation of protein/creatinine ratio.

The instrument operates with continuous loading and throughput of 400 tests per hour. Convenient sample identification and data input via barcode reader and LIS connectivity minimize potential data management errors and reflect the need for increased efficiency and safety. The intuitive user interface has been designed to offer a broad range of optimized features such as results flagging and recommendation for additional sediment evaluation or customized reporting options.

Overall, the LAURA reader, with PHAN diagnostic strips and URINORM control urines, provides a complete solution to optimize laboratory workflow. This instrument offers affordable automation for smaller and mid-sized labs, or serves as reliable backup system for fully automated larger labs.

The LAURA XL is a fully automated urine analyzer combining trusted urine strip analysis and digital microscopy. It offers automatic evaluation of 10 chemistry parameters and 16 sediment categories. In addition, users can select from 16 manual and four customizable sediment categories. Concentration of sediment particles is achieved without centrifugation by gravitational sedimentation.

This is a very gentle technique preventing damage of fragile elements and allowing cost-effective measurement by replacing disposable cuvettes with a long-life, washable cuvette module. Due to clear high-resolution imagery, LAURA XL reduces the need for additional evaluation of results by visual microscopy.

The LAURA XL system - a powerful tool for larger labs looking for a high-performance solution to automate their routine urinalysis requirements - is delivered with special adaptors, which enable measurement of low volume samples - minimal volume for analysis of both urine chemistry and sediment is then 0.9 microliters of urine. It operates in three modes: chemistry only (180 tests/hour), sediment only (140 tests/hour), and hybrid (140 tests/hour).

The LAURA and LAURA XL clinical urinalysis systems were developed and are being introduced by Erba Mannheim (Mannheim, Germany), a global IVD company focused on delivering total solutions for clinical diagnostics.


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test
New
Unstirred Waterbath
HumAqua 5

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more